Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Email
Tweet
Print
Alison T. Kawai, ScD, ScM
Director, Epidemiology
RTI Health Solutions
Poster(s):
(347) Interim Utilization Results from a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
Email Alison